ArticleJAMA network open2023

Association Between Anti-CD20 Therapies and COVID-19 Severity Among Patients With Relapsing-Remitting and Progressive Multiple Sclerosis.

Edouard Januel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.